サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1414086

心臓バイオマーカーの世界市場レポート 2024年

Cardiac Biomarkers Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
心臓バイオマーカーの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

心臓バイオマーカーの市場規模は近年急速に拡大しています。2023年の172億2,000万米ドルから2024年には194億8,000万米ドルへと、CAGR13.1％で拡大します。過去に観察された成長は、いくつかの重要な要因に遡ることができます。これには、医療支出の顕著な増加、FDA承認と規制支援の促進、高齢化人口動態の変化、広範な啓発プログラム、高感度トロポニン検査の進歩、心血管疾患の有病率の同時増加などが含まれます。これらの要因が、心臓バイオマーカーおよび関連診断薬領域におけるこの時期の成長に寄与しました。

2023年の心臓バイオマーカー市場で最大の地域は北米でした。心臓バイオマーカー市場レポートの対象地域は、アジア太平洋,西欧,東欧,北米,南米,中東,アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018～2023年
  • 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の心臓バイオマーカー市場、バイオマーカータイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • クレアチンキナーゼ（CK-Mb）
  • トロポニン
  • ミオグロビン
  • ナトリウム利尿ペプチド（BNP・NT-proBNP）
  • 虚血変性アルブミン（IMA）
  • その他
  • 世界の心臓バイオマーカー市場、検査場所別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ポイントオブケア検査
  • 臨床検査
  • 世界の心臓バイオマーカー市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 心筋梗塞
  • うっ血性心不全
  • 急性冠症候群（ACS）
  • アテローム性動脈硬化症
  • その他
  • 世界の心臓バイオマーカー市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 専門クリニック

第7章 地域および国の分析

  • 世界の心臓バイオマーカー市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の心臓バイオマーカー市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 心臓バイオマーカー市場の競合情勢
  • 心臓バイオマーカー市場の企業プロファイル
    • BioMerieux Inc.
    • Bio-Rad Laboratories
    • F. Hoffmann-La Roche AG
    • Siemens AG
    • Thermo Fisher Scientific Inc.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r11596

“Cardiac Biomarkers Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac biomarkers? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The cardiac biomarkers market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Biomarkers Type: Creatine Kinase (CK-Mb); Troponins; Myoglobin; Natriuretic Peptides (BNP And NT-proBNP); Ischemia Modified Albumin (IMA); Other Biomarker Types
  • 2) By Location Of Testing: Point Of Care Testing; Laboratory Testing
  • 3) By Application: Myocardial Infarction; Congestive Heart Failure; Acute Coronary Syndrome (ACS); Atherosclerosis; Other Applications
  • 4) By End User: Hospitals; Specialty Clinics
  • Companies Mentioned: bioMerieux Inc.; Bio-Rad Laboratories; F. Hoffmann-La Roche AG; Siemens AG; Thermo Fisher Scientific Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Cardiac biomarkers represent substances released by the heart into the bloodstream during periods of injury or stress, aiding in the detection and measurement of various cardiac and vascular conditions.

The primary categories of cardiac biomarkers encompass creatine kinase (CK-MB), troponins, myoglobin, natriuretic peptides (BNP and NT-proBNP), ischemia-modified albumin (IMA), among others. Creatine kinase (CK) is an enzyme present in multiple body tissues, including muscles and the brain, commonly utilized in diagnosing myocardial infarction (MI), commonly known as a heart attack. These biomarkers find application across diverse testing settings such as point-of-care and laboratory-based assessments. They serve multiple diagnostic purposes, including testing for myocardial infarction, congestive heart failure, acute coronary syndrome (ACS), atherosclerosis, among other cardiac conditions. Hospitals and specialized clinics heavily rely on these biomarkers in their diagnostic protocols.

The cardiac biomarkers market research report is one of a series of new reports from The Business Research Company that provides cardiac biomarkers market statistics, including cardiac biomarkers industry global market size, regional shares, competitors with a cardiac biomarkers market share, detailed cardiac biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac biomarkers industry. This cardiac biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac biomarkers market size has grown rapidly in recent years. It will grow from $17.22 billion in 2023 to $19.48 billion in 2024 at a compound annual growth rate (CAGR) of 13.1%. The growth observed in the past period can be traced back to several key factors. These include a notable rise in healthcare expenditure, the facilitation of FDA approvals and regulatory support, demographic shifts toward an aging population, extensive awareness programs, advancements in high-sensitivity troponin tests, and a concurrent increase in the prevalence of cardiovascular diseases. These factors collectively contributed to the growth experienced during that timeframe in the realm of cardiac biomarkers and related diagnostics.

The cardiac biomarkers market size is expected to see rapid growth in the next few years. It will grow to $31.88 billion in 2028 at a compound annual growth rate (CAGR) of 13.1%. The anticipated growth in the forthcoming period is poised to result from several driving forces. These encompass the escalating burden of chronic diseases, an increased emphasis on early disease detection initiatives, the continual expansion of the geriatric population, ongoing development in emerging markets, and a heightened focus on the utilization of biomarker panels.

The anticipated surge in cardiac biomarker market growth is closely linked to the increasing prevalence of cardiovascular disorders. These ailments encompass a range of heart and blood vessel conditions, including coronary artery disease, heart failure, and strokes. Cardiac biomarkers, released into the bloodstream due to specific cardiovascular disorders such as heart attacks, heart failure, and arrhythmias, offer vital diagnostic and prognostic information when measured via laboratory tests. For instance, the Centers for Disease Control and Prevention reported that in 2021, coronary artery disease (CAD) claimed 375,476 lives, affecting approximately 1 in 20 adults aged 20 and older. Alarmingly, about 2 in 10 CAD-related deaths occur in individuals under 65 years old. Hence, the escalating prevalence of cardiovascular disorders significantly fuels the growth of the cardiac biomarker market.

The upsurge in healthcare expenditures stands as a catalyst for the burgeoning cardiac biomarker market. Health expenditures encompass all costs associated with delivering health services, including cardiac biomarker-related expenses aiming to enhance early detection, personalized treatment, and effective resource allocation for cardiovascular diseases. For example, the Centers for Medicare & Medicaid Services reported a 2.7% increase, totaling $12,914 per person in healthcare spending in the United States in 2021, amounting to $4.3 trillion. Notably, healthcare spending constituted 18.3% of the country's GDP. Thus, the surge in healthcare expenditures significantly drives the expansion of the cardiac biomarker market.

Technological advancements represent a pivotal trend gaining momentum in the cardiac biomarker market. Companies within this sector are actively embracing new technologies to fortify their market positions. For instance, Roche Diagnostics introduced five new solutions utilizing Elecsys technology in April 2021, catering to two vital cardiac biomarkers, highly sensitive cardiac troponin T (cTnT-hs) and the N-terminal pro-brain natriuretic peptide test (NT-proBNP). These solutions aid in cardiac risk identification, improving diagnosis, and facilitating early treatment by identifying cardiovascular risk factors.

Prominent companies in the cardiac biomarker market are dedicated to developing innovative assays to expand their product portfolios, aiming to enhance patient outcomes and address unmet medical needs. These innovative biomarker assays contribute to advancements in cardiac diagnostics, improving accuracy and diagnostic capabilities. For instance, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. launched two new cardiac biomarkers, high-sensitivity troponin I (hs-cTnI) and NT-proBNP. These additions augment Mindray's varied portfolio of cardiac biomarkers, bolstering capabilities in diagnosing and managing cardiovascular diseases (CVDs).

In September 2021, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a China-based leader in medical devices and solutions, completed the acquisition of HyTest Ltd. The acquisition's financial details remain undisclosed. Through this strategic move, Mindray seeks to solidify its standing within the global In-Vitro Diagnostics (IVD) market while extending its reach into Europe and other international markets. Furthermore, the acquisition aims to bolster Mindray's ongoing research and development initiatives, fostering the exploration of novel technologies and fostering collaborations within academic circles. HyTest Ltd., headquartered in Finland, specializes in providing in-vitro diagnostic reagents, particularly excelling in the field of cardiac biomarkers.

Major companies operating in the cardiac biomarkers market report are bioMerieux Inc., Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Siemens AG, Thermo Fisher Scientific Inc., Creative Diagnostics, Randox Laboratories Ltd., Becton Dickinson and Company, Tosoh Corporation, Life Diagnostics, PerkinElmer Inc., Quidel Corporation, ACS Biomarker BV, LSI Medience Corp., BioDot, Alere Inc., Biosensors International Group, Biosynex SA, CardioGenics Holdings Inc., Danaher Corporation, Cortez Diagnostics Inc., DIALAB GmbH, Eurolyser Diagnostica GmbH, Grifols SA, Hologic Inc., InfraRedx Inc., Labcorp Corp., Lepu Medical Technology, Myriad Genetics, Nanosphere Inc., Biora Therapeutics Inc., Quest Diagnostics

North America was the largest region in the cardiac biomarkers market in 2023. The regions covered in the cardiac biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cardiac biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiac biomarkers market consists of sales of assays and reagents, point-of-care testing (POCT) devices, instruments, and software solutions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Cardiac Biomarkers Market Characteristics

3. Cardiac Biomarkers Market Trends And Strategies

4. Cardiac Biomarkers Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Cardiac Biomarkers Market Size and Growth

  • 5.1. Global Cardiac Biomarkers Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cardiac Biomarkers Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cardiac Biomarkers Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cardiac Biomarkers Market Segmentation

  • 6.1. Global Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Creatine Kinase (CK-Mb)
  • Troponins
  • Myoglobin
  • Natriuretic Peptides (BNP And NT-proBNP)
  • Ischemia Modified Albumin (IMA)
  • Other Biomarker Types
  • 6.2. Global Cardiac Biomarkers Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Point Of Care Testing
  • Laboratory Testing
  • 6.3. Global Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome (ACS)
  • Atherosclerosis
  • Other Applications
  • 6.4. Global Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics

7. Cardiac Biomarkers Market Regional And Country Analysis

  • 7.1. Global Cardiac Biomarkers Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cardiac Biomarkers Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cardiac Biomarkers Market

  • 8.1. Asia-Pacific Cardiac Biomarkers Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cardiac Biomarkers Market

  • 9.1. China Cardiac Biomarkers Market Overview
  • 9.2. China Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cardiac Biomarkers Market

  • 10.1. India Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cardiac Biomarkers Market

  • 11.1. Japan Cardiac Biomarkers Market Overview
  • 11.2. Japan Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cardiac Biomarkers Market

  • 12.1. Australia Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cardiac Biomarkers Market

  • 13.1. Indonesia Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cardiac Biomarkers Market

  • 14.1. South Korea Cardiac Biomarkers Market Overview
  • 14.2. South Korea Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cardiac Biomarkers Market

  • 15.1. Western Europe Cardiac Biomarkers Market Overview
  • 15.2. Western Europe Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cardiac Biomarkers Market

  • 16.1. UK Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cardiac Biomarkers Market

  • 17.1. Germany Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cardiac Biomarkers Market

  • 18.1. France Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cardiac Biomarkers Market

  • 19.1. Italy Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cardiac Biomarkers Market

  • 20.1. Spain Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cardiac Biomarkers Market

  • 21.1. Eastern Europe Cardiac Biomarkers Market Overview
  • 21.2. Eastern Europe Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cardiac Biomarkers Market

  • 22.1. Russia Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cardiac Biomarkers Market

  • 23.1. North America Cardiac Biomarkers Market Overview
  • 23.2. North America Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cardiac Biomarkers Market

  • 24.1. USA Cardiac Biomarkers Market Overview
  • 24.2. USA Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cardiac Biomarkers Market

  • 25.1. Canada Cardiac Biomarkers Market Overview
  • 25.2. Canada Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cardiac Biomarkers Market

  • 26.1. South America Cardiac Biomarkers Market Overview
  • 26.2. South America Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cardiac Biomarkers Market

  • 27.1. Brazil Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cardiac Biomarkers Market

  • 28.1. Middle East Cardiac Biomarkers Market Overview
  • 28.2. Middle East Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cardiac Biomarkers Market

  • 29.1. Africa Cardiac Biomarkers Market Overview
  • 29.2. Africa Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cardiac Biomarkers Market Competitive Landscape And Company Profiles

  • 30.1. Cardiac Biomarkers Market Competitive Landscape
  • 30.2. Cardiac Biomarkers Market Company Profiles
    • 30.2.1. BioMerieux Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Bio-Rad Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Siemens AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Thermo Fisher Scientific Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Cardiac Biomarkers Market Competitive Benchmarking

32. Global Cardiac Biomarkers Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Cardiac Biomarkers Market

34. Cardiac Biomarkers Market Future Outlook and Potential Analysis

  • 34.1 Cardiac Biomarkers Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Cardiac Biomarkers Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Cardiac Biomarkers Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer